• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本小儿肥厚型和限制型心肌病患者的遗传背景。

Genetic background of Japanese patients with pediatric hypertrophic and restrictive cardiomyopathy.

机构信息

Department of Molecular Pathogenesis, Medical Research Institute, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.

Department of Cardiology, Keio University School of Medicine, 35 Shinanomachi, Shinjyuku-ku, Tokyo, 160-8582, Japan.

出版信息

J Hum Genet. 2018 Sep;63(9):989-996. doi: 10.1038/s10038-018-0479-y. Epub 2018 Jun 15.

DOI:10.1038/s10038-018-0479-y
PMID:29907873
Abstract

Hypertrophic cardiomyopathy (HCM) and restrictive cardiomyopathy (RCM) present a high risk for sudden cardiac death in pediatric patients. The aim of this study was to identify disease-associated genetic variants in Japanese patients with pediatric HCM and RCM. We analyzed 67 cardiomyopathy-associated genes in 46 HCM and 7 RCM patients diagnosed before 16 years of age using a next-generation sequencing system. We found that 78% of HCM and 71% of RCM patients carried disease-associated genetic variants. Disease-associated genetic variants were identified in 80% of HCM patients with a family history and in 77% of HCM patients with no apparent family history (NFH). MYH7 and/or MYBPC3 variants comprised 76% of HCM-associated variants, whereas troponin complex-encoding genes comprised 75% of the RCM-associated variants. In addition, 91% of HCM patients with implantable cardioverter-defibrillators and infant cases had NFH, and the 88% of HCM patients carrying disease-associated genetic variants were males who carried MYH7 or MYBPC3 variants. Moreover, two disease-associated LAMP2, one DES and one FHOD3 variants, were identified in HCM patients. In this study, pediatric HCM and RCM patients were found to carry disease-associated genetic variants at a high rate. Most of the variants were in MYH7 or MYPBC3 for HCM and TNNT2 or TNNI3 for RCM.

摘要

肥厚型心肌病(HCM)和限制型心肌病(RCM)使儿科患者有发生心源性猝死的高风险。本研究旨在鉴定日本儿科 HCM 和 RCM 患者中的疾病相关遗传变异。我们使用下一代测序系统分析了 67 个与心肌病相关的基因,涉及 46 名 HCM 患者和 7 名 RCM 患者。结果发现,78%的 HCM 患者和 71%的 RCM 患者携带疾病相关的遗传变异。有家族史的 HCM 患者中有 80%、无明显家族史的 HCM 患者中有 77%(NFH)携带疾病相关的遗传变异。MYH7 和/或 MYBPC3 变异占 HCM 相关变异的 76%,而肌钙蛋白复合物编码基因占 RCM 相关变异的 75%。此外,91%携带植入式心脏复律除颤器的 HCM 患者和婴儿病例为 NFH,携带疾病相关遗传变异的 88%HCM 患者为男性,携带 MYH7 或 MYBPC3 变异。此外,还在 HCM 患者中鉴定出两种疾病相关的 LAMP2、一种 DES 和一种 FHOD3 变异。在这项研究中,发现儿科 HCM 和 RCM 患者携带疾病相关遗传变异的比例很高。大多数变异存在于 HCM 中的 MYH7 或 MYBPC3,以及 RCM 中的 TNNT2 或 TNNI3。

相似文献

1
Genetic background of Japanese patients with pediatric hypertrophic and restrictive cardiomyopathy.日本小儿肥厚型和限制型心肌病患者的遗传背景。
J Hum Genet. 2018 Sep;63(9):989-996. doi: 10.1038/s10038-018-0479-y. Epub 2018 Jun 15.
2
Diagnostic disparity and identification of two TNNI3 gene mutations, one novel and one arising de novo, in South African patients with restrictive cardiomyopathy and focal ventricular hypertrophy.南非限制性心肌病和局灶性心室肥厚患者的诊断差异以及两个TNNI3基因突变的鉴定,其中一个为新发现的突变,另一个为新发突变。
Cardiovasc J Afr. 2015 Mar-Apr;26(2):63-9. doi: 10.5830/CVJA-2015-019.
3
Genetic and clinical profile of Indian patients of idiopathic restrictive cardiomyopathy with and without hypertrophy.特发性限制型心肌病伴或不伴肥厚的印度患者的遗传和临床特征。
Mol Cell Biochem. 2009 Nov;331(1-2):187-92. doi: 10.1007/s11010-009-0157-7. Epub 2009 May 17.
4
Association of variants in MYH7, MYBPC3 and TNNT2 with sudden cardiac death-related risk factors in Brazilian patients with hypertrophic cardiomyopathy.MYH7、MYBPC3 和 TNNT2 变异与巴西肥厚型心肌病患者与心源性猝死相关危险因素的关联。
Forensic Sci Int Genet. 2021 May;52:102478. doi: 10.1016/j.fsigen.2021.102478. Epub 2021 Feb 3.
5
Investigation of de novo variation in pediatric cardiomyopathy.小儿心肌病新生变异的研究。
Am J Med Genet C Semin Med Genet. 2020 Mar;184(1):116-123. doi: 10.1002/ajmg.c.31764. Epub 2020 Jan 8.
6
Genetic screening and double mutation in Japanese patients with hypertrophic cardiomyopathy.日本肥厚型心肌病患者的基因筛查和双突变。
Circ J. 2011;75(11):2654-9. doi: 10.1253/circj.cj-10-1314. Epub 2011 Jul 29.
7
Genetic Studies of Hypertrophic Cardiomyopathy in Singaporeans Identify Variants in and That Are Common in Chinese Patients.新加坡人肥厚型心肌病的遗传学研究确定了 和 中的变异,这些变异在中国患者中很常见。
Circ Genom Precis Med. 2020 Oct;13(5):424-434. doi: 10.1161/CIRCGEN.119.002823. Epub 2020 Aug 20.
8
Outcomes of restrictive cardiomyopathy in childhood and the influence of phenotype: a report from the Pediatric Cardiomyopathy Registry.儿童限制性心肌病的结局及其表型的影响:来自儿科心肌病登记处的报告。
Circulation. 2012 Sep 4;126(10):1237-44. doi: 10.1161/CIRCULATIONAHA.112.104638. Epub 2012 Jul 27.
9
Meta-analysis of cardiomyopathy-associated variants in troponin genes identifies loci and intragenic hot spots that are associated with worse clinical outcomes.肌钙蛋白基因中心肌病相关变异的荟萃分析确定了与更差临床结局相关的基因座和基因内热点。
J Mol Cell Cardiol. 2020 May;142:118-125. doi: 10.1016/j.yjmcc.2020.04.005. Epub 2020 Apr 9.
10
First identification of homozygous truncating CSRP3 variants in two unrelated cases with hypertrophic cardiomyopathy.首次在两例无关联的肥厚型心肌病患者中鉴定出 CSRP3 基因纯合截断变异。
Gene. 2018 Nov 15;676:110-116. doi: 10.1016/j.gene.2018.07.036. Epub 2018 Jul 17.

引用本文的文献

1
Troponin I - a comprehensive review of its function, structure, evolution, and role in muscle diseases.肌钙蛋白I——对其功能、结构、进化及在肌肉疾病中的作用的全面综述。
Anim Cells Syst (Seoul). 2025 Jul 28;29(1):446-468. doi: 10.1080/19768354.2025.2533821. eCollection 2025.
2
History and Perspective of LAMP-2 Deficiency (Danon Disease).LAMP-2 缺乏症(Danon 病)的历史和展望。
Biomolecules. 2024 Oct 9;14(10):1272. doi: 10.3390/biom14101272.
3
Identification of a novel likely pathogenic TPM1 variant linked to hypertrophic cardiomyopathy in a family with sudden cardiac death.

本文引用的文献

1
Phenotypic expression of a novel desmin gene mutation: hypertrophic cardiomyopathy followed by systemic myopathy.一种新型结蛋白基因突变的表型表达:肥厚型心肌病后继发全身性肌病。
J Hum Genet. 2018 Feb;63(2):249-254. doi: 10.1038/s10038-017-0383-x. Epub 2017 Nov 22.
2
Genetics and genomics of dilated cardiomyopathy and systolic heart failure.扩张型心肌病和收缩性心力衰竭的遗传学与基因组学
Genome Med. 2017 Feb 22;9(1):20. doi: 10.1186/s13073-017-0410-8.
3
Clinical and Mechanistic Insights Into the Genetics of Cardiomyopathy.心肌病遗传学的临床与机制见解
鉴定一个与肥厚型心肌病相关的新型 TPM1 变异,该变异与一个伴有心源性猝死的家族有关。
ESC Heart Fail. 2024 Oct;11(5):3180-3190. doi: 10.1002/ehf2.14906. Epub 2024 Jun 14.
4
Multinational experience with next-generation sequencing: opportunity to identify transthyretin cardiac amyloidosis and Fabry disease.下一代测序的跨国经验:识别转甲状腺素蛋白心脏淀粉样变性和法布里病的机会。
Cardiovasc Diagn Ther. 2024 Apr 30;14(2):294-303. doi: 10.21037/cdt-23-191. Epub 2024 Mar 18.
5
Pediatric hypertrophic cardiomyopathy caused by a novel TNNI3 variant.由一种新型TNNI3变异引起的小儿肥厚型心肌病。
Hum Genome Var. 2024 Mar 29;11(1):14. doi: 10.1038/s41439-024-00272-1.
6
Hypertrophic Cardiomyopathy versus Storage Diseases with Myocardial Involvement.肥厚型心肌病与心肌受累的贮积病的比较。
Int J Mol Sci. 2023 Aug 26;24(17):13239. doi: 10.3390/ijms241713239.
7
[Recent research on childhood hypertrophic cardiomyopathy caused by gene mutations].[关于基因突变所致儿童肥厚型心肌病的最新研究]
Zhongguo Dang Dai Er Ke Za Zhi. 2023 Apr 15;25(4):425-430. doi: 10.7499/j.issn.1008-8830.2211044.
8
Case Report: Danon Disease: Six Family Members and Literature Review.病例报告:达农病:六名家庭成员及文献综述
Front Cardiovasc Med. 2022 May 20;9:842282. doi: 10.3389/fcvm.2022.842282. eCollection 2022.
9
Clinical genetic testing in four highly suspected pediatric restrictive cardiomyopathy cases.对 4 例高度疑似小儿限制型心肌病进行临床遗传学检测。
BMC Cardiovasc Disord. 2022 May 25;22(1):240. doi: 10.1186/s12872-022-02675-w.
10
Formins in Human Disease.《人类疾病中的形成蛋白》
Cells. 2021 Sep 27;10(10):2554. doi: 10.3390/cells10102554.
J Am Coll Cardiol. 2016 Dec 27;68(25):2871-2886. doi: 10.1016/j.jacc.2016.08.079.
4
New insights into the generation and role of de novo mutations in health and disease.关于新生突变在健康与疾病中的产生及其作用的新见解。
Genome Biol. 2016 Nov 28;17(1):241. doi: 10.1186/s13059-016-1110-1.
5
The validation of pharmacogenetics for the identification of Fabry patients to be treated with migalastat.用于识别拟接受米加司他治疗的法布里病患者的药物遗传学验证。
Genet Med. 2017 Apr;19(4):430-438. doi: 10.1038/gim.2016.122. Epub 2016 Sep 22.
6
Analysis of protein-coding genetic variation in 60,706 humans.对60706名人类的蛋白质编码基因变异进行分析。
Nature. 2016 Aug 18;536(7616):285-91. doi: 10.1038/nature19057.
7
How Hypertrophic Cardiomyopathy Became a Contemporary Treatable Genetic Disease With Low Mortality: Shaped by 50 Years of Clinical Research and Practice.肥厚型心肌病如何成为一种当代可治疗、低死亡率的遗传性疾病:50 年临床研究与实践的塑造。
JAMA Cardiol. 2016 Apr 1;1(1):98-105. doi: 10.1001/jamacardio.2015.0354.
8
Human genetic variation database, a reference database of genetic variations in the Japanese population.人类遗传变异数据库,一个关于日本人群体遗传变异的参考数据库。
J Hum Genet. 2016 Jun;61(6):547-53. doi: 10.1038/jhg.2016.12. Epub 2016 Feb 25.
9
A global reference for human genetic variation.人类遗传变异的全球参考。
Nature. 2015 Oct 1;526(7571):68-74. doi: 10.1038/nature15393.
10
Molecular genetics and pathogenesis of cardiomyopathy.心肌病的分子遗传学与发病机制
J Hum Genet. 2016 Jan;61(1):41-50. doi: 10.1038/jhg.2015.83. Epub 2015 Jul 16.